Cytiva and LevitasBio signed an agreement to jointly work on delivering an advanced single-cell workflow for genomics researchers in academia and industry. The collaboration marks a significant ...
Pierre-Alain Ruffieux, Cytiva’s group executive, bioprocess, discusses completion of the doubling of the company’s liquid ...
Cambridge, UK and Marlborough, MA, 28 May 2025: Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a ...
In academic and industrial protein research, speed, accuracy, and accessibility are essential. After purifying proteins using ÄKTA™ chromatography systems from Cytiva, researchers often turn to ...
Accelerating protein production with high reproducibility is a key challenge in drug discovery and development. In this webinar, Karthik Rajasekar from Evotec department of Protein Sciences will ...
- A survey of 1,165 biopharma executives and healthcare policymakers across 20 countries measured ability of industry to respond to global needs in five areas: Supply chain resilience, talent pool, ...
Nuclera, has announced a collaboration with Cytiva. This collaboration is focused on accelerating the production, purification and characterization of proteins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results